Inhibition of blood platelet aggregation by dioxo-ene compounds

Area of Science:

• Biochemistry
• Pharmacology
• Organic Chemistry

Background:

• Blood platelet aggregation is a critical process in hemostasis and thrombosis.
• Dysregulated platelet aggregation contributes to cardiovascular diseases.
• Identifying novel inhibitors of platelet aggregation is crucial for therapeutic development.

Purpose of the Study:

• To investigate the anti-platelet aggregation activity of compounds containing an oxo-ene-oxo system.
• To determine the structural requirements for this inhibitory activity.
• To elucidate the mechanism of action of these novel inhibitors.

Main Methods:

• Synthesis and characterization of various oxo-ene-oxo compounds.
• In vitro testing of platelet aggregation inhibition induced by thrombin and arachidonic acid.
• Mechanistic studies using specific inhibitors to probe arachidonic acid metabolism and release.

Main Results:

• Compounds with a trans-configured oxo-ene-oxo system demonstrated potent inhibition of platelet aggregation.
• Effective inhibitors include dioxo-octadecenoic acids, dioxo-eicosenoic acid, dioxo-decene, and trans-dibenzoylethylene.
• Half-maximal inhibitory concentrations were observed in the low micromolar range (2-6 µM).
• Inhibition appears to block thrombin-induced release of endogenous arachidonic acid and may affect other aggregation pathways.
• Potential mechanism involves reaction with sulfhydryl (SH) groups.

Conclusions:

• The oxo-trans-ene-oxo moiety is a pharmacophore for potent anti-platelet activity.
• These compounds represent a promising class of agents for managing thrombotic disorders.
• Further research into the precise mechanism and in vivo efficacy is warranted.